Virtual screening and fast automated docking methods

Drug Discovery Today

Volumn 7, Issue 1, 2002, Pages 64-70

  Schneider, Gisbert ^a   Böhm, Hans Joachim ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; CALCIUM ANTAGONIST; CYCLOTHIALIDINE; GYRASE INHIBITOR; LIGAND; NOVOBIOCIN; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN FARNESYLTRANSFERASE INHIBITOR; THROMBIN INHIBITOR; UNCLASSIFIED DRUG; DNA TOPOISOMERASE (ATP HYDROLYSING); ENZYME INHIBITOR; CYTOCHROME P450; G PROTEIN COUPLED RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE INHIBITOR;

ALGORITHM; AUTOMATION; COMBINATORIAL CHEMISTRY; DRUG ACTIVITY; DRUG DESIGN; DRUG IDENTIFICATION; REVIEW; SCREENING; VIRTUAL REALITY; CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; DRUG SCREENING; HUMAN; METHODOLOGY; SYNTHESIS; BLOOD BRAIN BARRIER; CHEMICAL STRUCTURE; PHARMACOPHORE; PHYSICAL CHEMISTRY; PROTEIN STRUCTURE;

COMBINATORIAL CHEMISTRY TECHNIQUES; DNA GYRASE; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; HUMANS; MOLECULAR CONFORMATION;

EID: 0036007208     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)02091-8     Document Type: Review

References (58)

1. High-throughput chemistry and structure-based design: Survival of the smartest
2. Computational methods for the prediction of 'drug-likeness'
3. Simple criteria for drug-like chemical matter
4. Virtual screening: An overview
5. The computer program LUDI: A new method for the de novo design of enzyme inhibitors
6. BUILDER v.2: Improving the chemistry of a de novo design strategy
7. Chemical similarity searching
8. Synergy between combinatorial chemistry and de novo design
9. RECAP - Retrosynthetic combinatorial analysis procedure: A powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry
10. De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks
11. QXP: Powerful, rapid computer algorithms for structure-based design
12. Screening a peptidyl database for potential ligands to proteins with side-chain flexibility
13. Molecular docking into the flexible active site of aldosereductase using FlexE
14. A fast flexible docking method using an incremental construction algorithm
15. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases
16. Development and validation of a genetic algorithm for flexible docking
17. Computational methods to predict binding free energy in ligand-receptor complexes
18. Predicting ligand binding energies
19. Rapid empirical scoring functions in virtual screening applications
20. Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins
21. Library design and virtual screening using multiple 4-point pharmacophore fingerprints
22. Statistical relationships among docking scores for different protein binding sites
23. Computational approaches to structure-based ligand design
24. Recent advances in structure-based rational drug design
25. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations
26. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening
27. Detailed analysis of scoring functions for virtual screening
28. Pharmacophore-based molecular docking
29. Development of a virtual screening method for identification of 'frequent hitters' in compound libraries
30. CAVEAT: A program to facilitate the design of organic molecules
31. CONCERTS: Dynamic connection of fragments as an approach to de novo ligand design
32. An automated method for dynamic ligand design
33. GenStar: A method for de novo drug design
34. GroupBuild: A fragment-based method for de novo drug design
35. Computer design of bioactive molecules: A method for receptor-based de novo ligand design
36. Multiple highly diverse structures complementary to enzyme binding sites: Results of extensive application of a de novo design method incorporating combinatorial growth
37. HOOK: A program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site
38. Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation
39. De novo design of enzyme inhibitors by Monte Carlo ligand generation
40. Functionality maps of binding sites: A multiple copy simultaneous search method
41. MOLMAKER: De novo generation of 3D databases for use in drug design
42. The NEWLEAD program: A new method for the design of candidate structures from pharmacophoric hypotheses
43. PRO-LIGAND: An approach to de novo molecular design. 1. Application to the design of organic molecules
44. PRO_SELECT: Combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology
45. Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design
46. Peptide design by artificial neural networks and computer-based evolutionary search
47. SMoG: De novo design method based on simple, fast, and accurate free energy estimates. 2. Case studies in molecular design
48. FOUNDATION: A program to retrieve all possible structures containing a user-defined minimum number of matching query elements from three-dimensional databases
49. SPROUT: A program for structure generation
50. Virtual screening for bioactive molecules by evolutionary de novo design
51. The discovery of steroids and other novel FKBP inhibitors using a molecular docking program
52. Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads
53. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design
54. Combinatorial docking and combinatorial chemistry: Design of potent non-peptide thrombin inhibitors
55. Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis
56. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR
57. Structure-based library design